The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Elevate-TN four-year follow up.
 
Jeff Porter Sharman
Employment - US Oncology Network
Stock and Other Ownership Interests - VelosBio
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Beigene; Bristol-Myers Squibb; Celgene; Genentech; Pfizer; Pharmacyclics; TG Therapeutics
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics (Inst)
 
Miklos Egyed
No Relationships to Disclose
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; BeiGene; Debiopharm Group; Loxo; MEI Pharma; Takeda
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Debiopharm Group (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Incyte (Inst); Janssen (Inst); Loxo (Inst); MEI Pharma (Inst); Nordic Nanovector (Inst)
 
Alan Skarbnik
Honoraria - Abbvie; Alexion Pharmaceuticals; AstraZeneca; BeiGene; Celgene; Genentech; Janssen; Jazz Pharmaceuticals; Pharmacyclics; Verastem
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; AstraZeneca; Celgene; Genentech; Janssen; Jazz Pharmaceuticals; Pharmacyclics
Speakers' Bureau - Abbvie; Alexion Pharmaceuticals; AstraZeneca; BeiGene; Celgene; Genentech; Janssen; Jazz Pharmaceuticals; Pharmacyclics; Verastem
 
John M. Pagel
Consulting or Advisory Role - Actinium Pharmaceuticals; AstraZeneca; BeiGene; Epizyme; Gilead Sciences; Loxo; MEI Pharma; MorphoSys; TG Therapeutics
 
Manali K. Kamdar
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; AstraZeneca; BeiGene; Celgene; Karyopharm Therapeutics; Pharmacyclics/Janssen
Speakers' Bureau - Seagen
Research Funding - TG Therapeutics (Inst)
 
Talha Munir
Honoraria - Abbvie; AstraZeneca; Gilead Sciences; Janssen; Novartis
Consulting or Advisory Role - AstraZeneca; Janssen; MorphoSys; Sunesis Pharmaceuticals
 
Gillian Corbett
Employment - Tauranga Hospital
Stock and Other Ownership Interests - Pathlab
Consulting or Advisory Role - Abbvie; Celgene
 
Laura Maria Fogliatto
No Relationships to Disclose
 
Yair Herishanu
Honoraria - AbbVie; AstraZeneca; Janssen; Roche
 
Versha Banerji
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen
Research Funding - Janssen
Patents, Royalties, Other Intellectual Property - Biogen
 
Steve E. Coutre
Stock and Other Ownership Interests - Abbvie/Pharmacyclics (I)
Honoraria - Abbvie; Janssen Oncology; Pharmacyclics
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; AstraZeneca; BeiGene; Genentech/Roche; Janssen Oncology; Pharmacyclics
Research Funding - Abbvie (Inst); Acerta Pharma/AstraZeneca (Inst); Janssen Oncology (Inst); Kite/Gilead; Pharmacyclics (Inst)
Expert Testimony - Genentech; Pharmacyclics
Travel, Accommodations, Expenses - abbvie; BeiGene; Celgene; Genentech; Janssen Oncology; Pharmacyclics
 
Patricia Walker
Employment - Alfred Health; Peninsula Health
Travel, Accommodations, Expenses - Roche
 
Karin Karlsson
No Relationships to Disclose
 
Paolo Ghia
Honoraria - Abbvie; ArQule; AstraZeneca; BeiGene; Gilead Sciences; Janssen; Juno/Celgene/Bristol-Myers Squibb; Loxo/Lilly
Consulting or Advisory Role - Abbvie; ArQule; AstraZeneca; BeiGene; Gilead Sciences; Janssen; Juno/Celgene/Bristol-Myers Squibb; Loxo/Lilly
Speakers' Bureau - Abbvie; Gilead Sciences; Janssen; Novartis; Sunesis Pharmaceuticals
 
Ann Janssens
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; BeiGene; Janssen; Novartis; Saudi; Takeda
Speakers' Bureau - Abbvie; BeiGene; Janssen
 
William G. Wierda
Consulting or Advisory Role - Sanofi
Research Funding - Abbvie; Acerta Pharma; Cyclacel; Emergent BioSolutions; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Loxo; miRagen; Oncternal Therapeutics, Inc; Pharmacyclics; Sunesis Pharmaceuticals; Xencor
 
Priti Patel
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Min Hui Wang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
John C. Byrd
Honoraria - AstraZeneca; Novartis; Novartis; Pharmacyclics; Syndax; Trillium Therapeutics
Consulting or Advisory Role - Acerta Pharma; Genentech; Jazz Pharmaceuticals; Pharmacyclics
Research Funding - Acerta Pharma (Inst); Pharmacyclics (Inst)